Hyperhomocysteinemia and thrombosis

Clinical and Laboratory Haematology

Volumn 22, Issue 3, 2000, Pages 133-143

  Makris, M ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Folate; Homocysteine; Homocystinuria; MTFHR; Thrombosis

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; PYRIDOXINE;

BRAIN INFARCTION; HEART INFARCTION; HOMOCYSTINURIA; HUMAN; HYPERHOMOCYSTEINEMIA; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; THROMBOSIS;

FEMALE; FOLIC ACID; HOMOCYSTEINE; HOMOCYSTINURIA; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; PREGNANCY; RISK FACTORS; THROMBOSIS;

EID: 0033887407     PISSN: 01419854     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2257.2000.00301.x     Document Type: Review

References (75)

1. Plasma homocysteine assay in the exploration of thrombosis in young subjects
2. Mutated 5,10-methylenetetrahydrofolate reductase and moderate hyperhomocysteinaemia
3. Hyperhomocysteinemia as a risk factor for arterial and venous disease. A review of evidence and relevance
4. Plasma homocyst (e) ine concentrations in pregnant and non-pregnant women with controlled folate intake
5. Elevated fasting total homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study
6. Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: The Framingham study
7. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: Probable benefits of increasing folic acid intake
8. Plasma homocysteine in venous thromboembolism
9. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: The results of a meta-analysis
10. Metabolic abnormalities detected in a survey of mentally backward individuals in Ireland
11. Fasting plasma homocysteine levels do not predict the occurrence of deep vein thrombosis after elective hip replacement surgery
12. Hyperhomocysteinemia, atherosclerosis and thrombosis
13. Acute hyperhomocysteinaemia and endothelial dysfunction
14. Hyperhomocysteinemia: An independent risk factor for vascular disease
15. A hypercoagulable state in homocystinuria due to homozygous cystathionine β-synthase deficiency
16. Homocysteine and thrombotic disease
17. Hyperhomocysteinemia and protein S deficiency in complicated pregnancies
18. Hyperhomocysteinemia and venous thrombosis: A meta-analysis
19. Abnormally high thromboxane biosynthesis in homozygous homocystinuria - Evidence for platelet involvement and probucol-sensitive mechanism
20. Hyperhomocysteinemia is a risk factor of recurrent venous thromboembolism
21. Homocyst (e) ine and cardiovascular disease: A critical review of the epidemiological evidence
22. Oral administration of homocysteine leads to increased plasma triglycerides and homocysteic acid - Additional mechanisms in homocysteine induced endothelial damage
23. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahy-drofolate reductase
24. Seven novel mutations in the methylenetetrahydrofolate reductase gene and genotype/phenotype correlations in severe ethylenetetrahydrofolate reductase deficiency
25. Effect of homocysteine and homocystine on platelet and vascular arachidonic acid metabolism
26. Plasma homocysteine as a risk factor for vascular disease
27. Plasma concentrations of homocysteine and other aminothiol compounds are related to food intake in healthy subjects
28. Homocysteine and vascular disease
29. Homocysteinemia, vascular injury and arterial thrombosis
30. The role of endothelial cell injury and platelet response in its genesis
31. Platelets in homocystinuria
32. Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein (a) to fibrin: A potential biochemical link between thrombosis, atherogenesis and sulfhydryl compound metabolism
33. Kinetics and distribution of indium-labelled platelets in patients with homocystinuria
34. Lowering blood homocysteine with folic acid based supplements: Meta-analysis of randomised trials
35. Normalization of hyperhomocysteinemia with L-Thyroxine in hypothyroidism
36. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations
37. The effect of folic acid fortification on plasma folate and total homocysteine concentrations
38. Intermediate homocysteinemia: A thermolabile variant of methylenetetrahydrofolate reductase
39. Thermolabile methylenetetrahydrofolate reductase: An inherited risk factor for coronary artery disease
40. Nonfasting plasma total homocysteine level and mortality in middle aged and elderly men and women in Jerusalem
41. Levels of prothrombin fragment 1+2 in patients with hyperhomocysteinemia and a history of venous thromboembolism
42. Homocysteine inhibits von Willebrand factor processing and secretion by preventing transport from the endoplasmic reticulum
43. Vascular dysfunction in monkeys with diet induced hyperhomocysteinemia
44. Reduction of plasma homocysteine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease
45. Vascular pathology of homocysteinemia: Implications for the pathogenesis of atherosclerosis
46. Homocysteine theory of arteriosclerosis
47. Homocystinuria: An enzymatic defect
48. The natural history of homocystinuria due to cystathionine beta- synthase deficiency
49. Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end stage renal disease
50. Newborn screening for homocystinuria: Irish and world experience
51. Plasma homocysteine levels and mortality in patients with coronary artery disease
52. Eat right and take a multivitamin
53. Hyperhomocysteinemia and vascular disease
54. Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus
55. Method comparison for total homocysteine between the Abbott IMx analyser and an HPLC assay with internal standardization
56. Comparison of plasma total homocysteine measurements in 14 laboratories: An international study
57. Increased fetal loss in women with heritable thrombophilia
58. Elevated homocysteine levels with preeclampsia
59. Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease
60. Interrelation of hyperhomocyst (e) inemia, factor V Leiden, and risk of future venous thromboembolism
61. Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells
62. Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator
63. Genetic predisposition to hyperhomocysteinemia: Deficiency of methylenetetrahydrofolate reductase (MTHFR)
64. Homocysteine metabolism
65. Adverse vascular effects of homocysteine are modulated by endothelium derived relaxing factor and related oxides of nitrogen
66. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine
67. Maternal hyperhomocysteinemia: A risk factor for neural tube defects?
68. Clinical implications of plasma homocysteine measurement in cardiovascular disease
69. Hyperhomocyst (e) inemia is associated with impaired endothelium dependent vasodilation in humans
70. Promotion of vascular smooth muscle cell growth by homocysteine: A link to atherosclerosis
71. Homocystinuria: What about mild hyperhomocysteinaemia?
72. Changes in homocysteine levels during normal pregnancy
73. Homocysteine and atherosclerosis
74. The pathogenesis of coronary artery disease
75. Folic acid improves endothelial-dependent vasodilation in hyperhomocysteinemia